InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GFI | Ann: Monthly Activities and Cashflow Report February 2019 | 22/03/19 | 0 | 71 | |||
|
|||||||
GFI | Ann: Monthly Activities and Cashflow Report January 2019 | 22/03/19 | 0 | 57 | |||
|
|||||||
GFI | Ann: Quarterly Activities and Cashflow Report December 2018 | 22/03/19 | 0 | 52 | |||
|
|||||||
GFI | Ann: Monthly Activities and Cashflow Report December 2018 | 22/03/19 | 0 | 50 | |||
|
|||||||
GFI | Ann: Monthly Activities and Cashflow Report November 2018 | 22/03/19 | 0 | 53 | |||
|
|||||||
GFI | Ann: Monthly Activities and Cashflows Report October 2018 | 21/03/19 | 0 | 46 | |||
|
|||||||
GFI | Ann: Quarterly Activities and Cashflow Report September 2018 | 21/03/19 | 0 | 49 | |||
|
|||||||
GFI | Ann: Monthly Activities and Cashflow Report September 2018 | 21/03/19 | 0 | 46 | |||
|
See All Discussions